Statistics from Altmetric.com
Holz FG, Roider J, Ogura Y, et al. VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study. Br J Ophthalmol 2013;97:278–84.
Table 6 in the original article displayed severe adverse events instead of serious adverse events. The correct table of serious adverse events is now shown below.
In relation to the above corrected table, the sentence in the Safety section of the original article that states: “Two patients in the VTE2Q4 group and four patients in the sham group had ocular SAEs (table 6)” should read as “Three patients in the VTE2Q4 group and six patients in the sham group had ocular SAEs (table 6)”.